查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1159220

经皮吸收贴片的全球市场(2022年～2028年)

Transdermal Patches Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

全球经皮吸收贴片的市场规模在预测期间内预计将以相当的年复合成长率成长。透皮给药系统的技术进步和产品创新等各种战略的采用、增加产品发布和批准以及增加研发投资以促进透皮贴剂的进步，都有助于市场增长。

本报告提供全球经皮吸收贴片市场相关调查分析，提供市场趋势，市场区隔分析，地区分析，企业简介等资讯。

目录

第1章 报告摘要

第2章 市场概要与考察

  • 调查范围
  • 分析师的考察和目前市场趋势

第3章 竞争情形

  • 主要企业的分析
    • 3M
    • Aveva
    • Fierce Pharma
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
  • 主要策略的分析
  • COVID-19对主要企业的影响

第4章 市场区隔

  • 全球经皮吸收贴片市场:各类型
    • 单层DIA(药物黏剂)
    • 多层DIA(药物黏剂)
    • 矩阵
  • 全球经皮吸收贴片市场:各用途
    • 止痛
    • 戒烟·减少烟支援
    • 膀胱过动症
    • 荷尔蒙疗法

第5章 地区的分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 其他地区

第6章 企业简介

  • Acrux Limited
  • Agile Therapeutics Inc.
  • Cipla Inc.
  • Glenmark
  • ImQuest Biosciences
  • Luye Pharma Group
  • Mylan N.V.
  • Purdue Pharma L.P.
  • Rusan Pharma
  • Teikoku Pharma USA, Inc.
Product Code: OMR2026314

Global Transdermal Patches Market Size, Share & Trends Analysis Report, By Type (Single-Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive and Matrix), By Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, and Hormonal Therapy), Forecast Period (2022-2028)

The global transdermal patches market is anticipated to grow at a substantial CAGR during the forecast period. Rising technological advancements in transdermal drug delivery systems, as well as increasing adoption of various strategies such as product innovation, increasing product launches and approvals, rising research and development investment for advancements in transdermal patches, are all contributing to market growth. Furthermore, during the forecast period, rising self-administration and home care drug delivery systems will generate lucrative growth opportunities for the global transdermal patches market.

The global transdermal patches market is segmented based on type and application. Based on the type, the market is sub-segmented into the single-layer drug-in-adhesive, multi-layer drug-in-adhesive and matrix. Based on the application, the market is sub-segmented into pain relief, smoking reduction and cessation aid, overactive bladder and hormonal therapy. Among these, hormonal therapy is propelling the growth of the market. The most common form of transdermal HT has always been patching formulations. As a result, due to the rising number of cases of hormonal issues, the market for transdermal patches is expected to grow. For instance, according to a New York Post in February 2019, A hormonal imbalance has affected nearly half of all women. In hormonal therapy, an estrogen patch (oestrogen patch) is a transdermal delivery device for estrogens such as estradiol and ethinylestradiol that can be used for menopausal hormone therapy, transgender feminizing hormone therapy, hormonal birth control, and other purposes.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the second-largest share in the market after the Asia Pacific. The presence of significant players and established healthcare infrastructure is projected to boost growth. For instance, in April 2021, BASF introduced 'Sacred Patch,' a new skincare active ingredient that promotes emotional well-being. Furthermore, the market is predicted to rise as a result of beneficial government efforts and an increase in the number of research partnerships.

The major companies serving the global transdermal patches market include Novartis AG, Fierce Pharma, 3M, Aveva, Teva Pharmaceutical Industries Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, Luye Pharma announced that it has received approval for Rivastigmine Multi-Day Transdermal Patch by the UK's Medicines and Healthcare Products Regulatory Agency. It is used for the treatment of mild to moderate dementia associated with Alzheimer's disease.

Research Methodology

The market study of the global transdermal patches market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Transdermal Patches Market Research and Analysis by Type.

2. Global Transdermal Patches Market Research and Analysis by Application.

The Report Covers:

  • Comprehensive Research Methodology of the global transdermal patches market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global transdermal patches market.
  • Insights about market determinants that are stimulating the global transdermal patches market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Transdermal Patches Market
  • Recovery Scenario of Global Transdermal Patches Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. 3M
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Aveva
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Fierce Pharma
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. Novartis AG
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
    • 3.1.5. Teva Pharmaceutical Industries Ltd.
      • 3.1.5.1. Overview
      • 3.1.5.2. Financial Analysis
      • 3.1.5.3. SWOT Analysis
      • 3.1.5.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

  • 4.1. Global Transdermal patches Market by Type
    • 4.1.1. Single-layer Drug-in-Adhesive
    • 4.1.2. Multi-layer Drug-in-Adhesive
    • 4.1.3. Matrix
  • 4.2. Global Transdermal patches Market by Application
    • 4.2.1. Pain Relief
    • 4.2.2. Smoking Reduction and Cessation Aid
    • 4.2.3. Overactive Bladder
    • 4.2.4. Hormonal Therapy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Acrux Limited
  • 6.2. Agile Therapeutics Inc.
  • 6.3. Cipla Inc.
  • 6.4. Glenmark
  • 6.5. ImQuest Biosciences
  • 6.6. Luye Pharma Group
  • 6.7. Mylan N.V.
  • 6.8. Purdue Pharma L.P.
  • 6.9. Rusan Pharma
  • 6.10. Teikoku Pharma USA, Inc.

LIST OF TABLES

  • 1. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL MATRIX TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 6. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 14. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 16. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL TRANSDERMAL PATCHES MARKET, 2022-2028 (%)
  • 4. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 8. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. US TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. CANADA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. UK TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. FRANCE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. GERMANY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. ITALY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. SPAIN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. REST OF EUROPE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. INDIA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. CHINA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. JAPAN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. REST OF THE WORLD TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)